Determination of methylphenidate and ritalinic acid in blood, plasma and oral fluid from adolescents and adults using protein precipitation and liquid chromatography tandem mass spectrometry-A method applied on clinical and forensic investigations

Journal of Pharmaceutical and Biomedical Analysis

Volumn 55, Issue 5, 2011, Pages 1050-1059

  Josefsson, Martin ^a,b   Rydberg, Irene ^b  

^a National Board of Forensic Medicine   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Blood; LC MS MS; Methylphenidate; Oral fluid; Ritalinic acid

Indexed keywords

AMPHETAMINE; ATOMOXETINE; BUPRENORPHINE; CARBAMAZEPINE; CITALOPRAM; DELORAZEPAM; DIAZEPAM; DULOXETINE; ENALAPRIL; FLUOXETINE; HYDROXYZINE; METHANOL; METHYLPHENIDATE; MIRTAZAPINE; MODAFINIL; MORPHINE; NORBUPRENORPHINE; NORDAZEPAM; OLANZAPINE; PARACETAMOL; PROPIOMAZINE; QUETIAPINE; RISPERIDONE; RITALINIC ACID; SERTRALINE; TAMOXIFEN; UNINDEXED DRUG; VENLAFAXINE; ZINC SULFATE; ZOLPIDEM;

ADOLESCENT; ADULT; AQUEOUS SOLUTION; ARTICLE; ATTENTION DEFICIT DISORDER; AUTOPSY; CALIBRATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG BLOOD LEVEL; ELECTROSPRAY; FEMALE; FORENSIC TOXICOLOGY; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MORNING DOSAGE; PLASMA; PRIORITY JOURNAL; STANDARD; TANDEM MASS SPECTROMETRY;

ADOLESCENT; ADULT; BLOOD; BODY FLUIDS; CALIBRATION; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; MALE; METHYLPHENIDATE; MIDDLE AGED; PLASMA; PROTEINS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 79956135195     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.03.009     Document Type: Article

References (24)

1. Teicher M.H., Polcari A., Foley M., Valente E., McGreenery C.E., Chang W.-W., McKay G., Midha K.K. Methylphenidate blood levels and therapeutic response in children with attention-deficit hyperactivity disorder I Effect of different dosing regimens. J. Child Adolesc. Psychopharmacol. 2006, 16:416-431.
2. Nair R., Moss S.B. Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride. Neuropsychiatr. Dis. Treat. 2009, 5:421-432.
3. Heal D.J., Pierce D.M. Methylpenidate and its isomers. Their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery system. CNS Drugs 2009, 20:713-738.
4. Faraj B.A., Israili Z.H., Perel J.M., Jenkins M.L., Holtzman S.G., Cucinell S.A., Dayton P.G. Metabolism and disposition of methylphenidate-14C: studies in man and animals. J. Pharmacol. Exp. Ther. 1974, 191:535-547.
5. Modi N.B., Lindemulder B., Gupta S.K. Single- and multiple-dose pharmacokinetics of an oral once-a day osmotic controlled-realease OROS® (methylphenidate HCl) formulation. J. Clin. Pharmacol. 2000, 40:379-388.
6. Markowitz J.S., Straughn A.B., Patrick K.S. Advances in the pharmacotherapy of attention-deficit hyperactivity disorder: focus on methylphenidate formulations. Pharmacotherapy 2003, 23:1281-1299.
7. Pappadopulos E., Jensen P.S., Chait A.R., Arnold L.E., Swanson J.M., Geenhill L.L., Hechtman L., Chuang S., Wells K.C., Pelham W., Cooper T., Elliott G., Newcorn J.H. Medication adherence in the MTA: Saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J. Am. Acad. Child Adolsesc. Phychiatry 2009, 48:501-509.
8. Parasrampuria D.A., Schoedel K.A., Scheller R., Gu J., Ciccone P., Silver S.A., Sellers E.M. Assesment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlle extended-relesase methylphenidate formulation in humans. J. Clin. Pharmacol. 2007, 47:1476-1488.
9. Zhu H.-J., Wang J.-S., Patrick K.S., Donovan J.L., DeVane C.L., Markowitz J.S. A novel HPLC fluorescence method for the quantification of methylphenidate in human plasma. J. Chromatogr. B 2007, 858:91-95.
10. Shinozuka T., Terada M., Tanaka E. Solid-phase extraction and analysis of 20 antidepressant drugs in human plasma by LC/MS with SSI method. Forensic Sci. Int. 2006, 162:108-112.
11. Marchei E., Muñoz J.A., García-Algar Ó., Pellegrini M., Vall O., Zuccaro P., Pichini S. Development and validation of a liquid chromatography-mass spectrometry assay for hair analysis of methylphenidate. Forensic Sci. Int. 2008, 176:42-46.
12. Marchei E., Farrè M., Pellegrini M., Rossi S., García-Algar Ó., Vall O., Pichini S. Liquid chromatography-electrospray ionization mass spectrometry determination of methylphenidate and ritalinic acid in conventional and non-conventional biological matrices. J. Pharm. Biomed. Anal. 2009, 49:434-439.
13. Ramos L., Bakhtiar R., Tse F.L.S. Liquid-liquid extraction using 96-well plate format in conjunction with liquid chromatography/tandem mass spectrometry for quantitative determination of methylphenidate (Ritalin) in human plasma. Rapid Commun. Mass Spectrom. 2000, 14:740-745.
14. Eichhorst J., Etter M., Lepage J., Lehotay D.C. Urinary screening for methylphenidate (Ritalin) abuse: a comparison of liquid chromatography-tandem mass spectrometry, gas chromatography-mass spectrometry, and immunoassay methods. Clin. Biochem. 2004, 37:175-183.
15. del Mar Ramirez Fernandez M., Laloup M., Wood M., De Boeck G., Lopez-Rivadulla M., Wallemacq P., Samyn N. Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine. J. Anal. Toxicol. 2007, 31:497-504.
16. Doerge D.R., Fogle C.M., Paule M.G., McCullagh M., Bajic S. Analysis of methylphenidate and its metabolite ritalinic acid in monkey plasma by liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 2000, 14:619-623.
17. Barbarin N., Mawhinney D.B., Black R., Henion J. High-throughput selected reaction monitoring liquid chromatography-mass spectrometry determination of methylphenidate and its major metabolite, ritalinic acid, in rat plasma employing monolithic columns. J. Chromatogr. B 2003, 783:73-83.
18. Ramos L., Bakhtiar R., Majumdar T., Hayes M., Tse F. Liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry enantiomeric separation of dl-threo-methylphenidate (Ritalin) using a macrocyclic antibiotic as the chiral selector. Rapid Commun. Mass Spectrom. 1999, 13:2054-2062.
19. Zhang J., Deng Y., Fang J., Mc Kay G. Enantioselective analysis of ritalinic acids in biological samples by using protein-based chiral stationary phase. Pharm. Res. 2003, 20:1881-1884.
20. Marchei E., Farrè M., Pellegrini M., García-Algar Ó., Vall O., Pacifici R., Pichini S. Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject. Forensic Sci. Int. 2010, 196:59-63.
21. Marchei E., Farrè M., Pardo R., García-Algar Ó., Pellegrini M., Pacifici R., Pichini S. Usefulness of sweat testing for detection of methylphenidate after fast- and extended-release drug administration: a pilot study. Ther. Drug Monit. 2010, 32:508-511.
22. Langel K., Engblom C., Pehrsson A., Gunnar T., Ariniemi K., Lillsunde P. Drug testing in oral fluid-evaluation of sample collection devices. J. Anal. Toxicol. 2008, 32:393-401.
23. Marchei E., Farré M., Pardo R., Garcia-Algar Ó., Pellegrini M., Pacifici R., Pichini S. Correlation between methylphenidate and rialinic acid concentrations in oral fluid. Clin. Chem. 2010, 56:585-592.
24. Schepers R.J.F., Oyler J.M., Joseph R.E., Cone E.J., Moolchan E.T., Huestis M.A. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin. Chem. 2003, 49:121-132.